James Lu


I am proud to be a trusted advisor to our clients in handling a wide range of transactions and contingencies in today’s complex, global business environment.

James is a co-founder of Cooley’s Shanghai office and the head of its corporate practice. James focuses on Asia-related corporate and securities transactions, including foreign direct investment, venture capital financing, private equity investments, mergers and acquisitions and public offerings. He also has broad experience advising clients on complex cross-border commercial transactions involving unique structures and contractual arrangements designed to comply with legal requirements in multiple jurisdictions, including licensing, joint venture, manufacturing and distribution arrangements in the life sciences and high-tech industries in Asia. James is a frequent speaker at local and international conferences and has spoken extensively on topics relating to Asia's venture capital and capital market environment.

Download full bio 


  • Singapore-based Grab’s Record SPAC Marks Southeast Asia’s Largest Ever US Equity Offering 

  • EpimAb Biotherapeutics Raises $120 Million Series C 

  • Luqa Ventures Sells to CMS 

  • Legal 500 Asia Pacific Highlights Cooley 

  • Crown Bioscience Enters Merger Agreement With JSR Corporation 

  • View all


  • University of San Diego School of Law
    JD, summa cum laude, Valedictorian, Order of the Coif, Outstanding Service Award

  • University of Illinois Urbana-Champaign
    MS, Biochemistry

  • University of Science and Technology of China
    BS, Biology

Admissions & Credentials


Registered to practice before the United States Patent & Trademark Office (USPTO)

Rankings & Accolades

    China Business Law Journal: China A-List Lawyers (2020 and 2021)